NCT04374994View on ClinicalTrials.gov

Daily Avanafil for Erectile Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

April 15, 2019

Study Completion Date

October 10, 2019

Conditions
Erectile Dysfunction
Interventions
DRUG

Avanafil 50 MG

Oral phosphodiesterase type 5 inhibitors

DRUG

Placebo oral tablet

lactose and maize starch, Egypt

Trial Locations (1)

21500

Faculty of Medicine, Alexandria University., Alexandria

All Listed Sponsors
lead

University of Alexandria

OTHER

NCT04374994 - Daily Avanafil for Erectile Dysfunction | Biotech Hunter | Biotech Hunter